This study investigates the use of bethanechol, an investigational medication, in combination with chemotherapy drugs gemcitabine and nab-paclitaxel.
The study evaluates the safety and tolerability of bethanechol when used with chemotherapy. It also examines how bethanechol might affect tumor growth and certain biomarkers related to nerve stimulation.
- Who can participate: Adults with pancreatic ductal adenocarcinoma planning to undergo neoadjuvant chemotherapy can participate. Participants must have adequate diagnostic tissue for analysis and be able to take oral medications.
- Study details: Participants will receive bethanechol along with chemotherapy. The study will monitor how well participants tolerate this combination. A placebo is not used in this study.